ifosfamide and docetaxel anhydrous

ifosfamide has been researched along with docetaxel anhydrous in 83 studies

Research

Studies (83)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	10 (12.05)	18.2507
2000's	41 (49.40)	29.6817
2010's	29 (34.94)	24.3611
2020's	3 (3.61)	2.80

Authors

Authors	Studies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Alim, Z; Beydemir, Ş	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Devriendt, D; Klastersky, J	1
de Bruijn, EA; Groult, V; Locci-Tonelli, D; Planting, AS; Pronk, LC; Schellens, JH; Schrijvers, D; van Oosterom, AT; Verweij, J	2
Büchholz, E; Drings, P; Manegold, C	1
Armstrong, J; Crown, J; Donnellan, P; Fennelly, D; Lynch, V; McDonnell, T; McNicholas, W; Rowan, S	1
Beijnen, JH; Crommentuyn, KM; Schellens, JH; van den Berg, JD	1
Fossella, FV; Rigas, J	1
Manegold, C	1
Brodowicz, T; Köstler, WJ; Wiltschke, C; Zielinski, CC	1
Belani, CP; Fossella, F; Rigas, JR	1
Ando, Y	1
Crawford, J; DeVore, R; Dunphy, F; Fossella, FV; Gamza, F; Gandara, D; Hammershaimb, L; Kalman, L; Karp, D; Kerr, RN; Kim, Y; Kris, M; Lee, JS; Miller, V; Moore, M; Natale, RR; Vokes, E	1
Glisson, BS; Hong, WK; Khuri, FR; Lippman, SM; Shin, DM	1
Bruno, R; De Bruijn, E; Highley, M; Locci-Tonelli, D; Pronk, L; Schrijvers, D; Van Oosterom, AT; Verweij, J	1
Sandler, A	1
Fossella, FV	1
Börgermann, C; Krege, S; Otto, T; Rembrink, V; Rübben, H	1
Bittner, C; Feyerabend, T; Peters, SO; Raap, M; Remmert, S; Robins, IH; Sieg, P; Sommer, K; Wiedemann, GJ	1
Lynch, TJ	1
Amann, G; Attems, Y; Brodowicz, T; Fiebiger, WC; Hejna, M; Köstler, WJ; Krainer, M; Tomek, S; Wiltschke, CH; Zielinski, CC	1
Boccieri, MG; Bruschi, G; Lo Re, G; Saracchini, S; Toffoli, G; Tumolo, S	1
Dimitropoulos, D; Kalofonos, HP; Kosmas, C; Makatsoris, T; Onyenadum, A; Rokana, S; Sepsas, E; Stavroyianni, N; Tsavaris, NB; Vadiaka, M	1
Hisada, T; Ito, T; Masuda, S; Mochida, A; Morinari, H; Nakahara, K; Nishi, K; Saito, K; Sasaki, S; Tahara, M; Yakumaru, K	1
Hensley, ML	1
Larsson, LI; Lichtenberg, J	1
Ackland, S; Hall, K; Levi, J; Lewis, C; Marx, G	1
Du, CW; Li, DR; Lin, W; Lin, Y; Lin, YC; Wu, MY	1
Chen, MC; Chen, YM; Lee, CS; Lin, WC; Perng, RP; Shih, JF; Tsai, CM	1
Gregoriou, A; Kosmas, C; Malamos, N; Polyzos, A; Rokana, S; Stavroyianni, N; Tsavaris, N	1
Badalamenti, G; Fulfaro, F; Gebbia, N; Russo, A; Valerio, MR	1
Hervonen, P; Jekunen, A; Kellokumpu-Lehtinen, P; Lefebvre, P	1
Im, YH; Jung, CW; Kang, WK; Kim, HJ; Kim, K; Kim, WS; Kwon, OJ; Lee, HG; Park, CH; Park, K; Rhee, CH; Song, SY	1
Chuman, H	1
Taniguchi, M; Watanabe, A	1
Kitamura, T; Kume, H; Matsumoto, S; Nishimatsu, H; Okamoto, N; Suzuki, M; Takahashi, S; Tomita, K	1
Chiudinelli, F; Colombo, N; Fanucchi, A; Gadducci, A; Landoni, F; Lapresa, M; Maggino, T; Maria Ferrero, A; Sartori, E; Zola, P	1
Bubis, JA; Dragnev, KH; Rigas, JR	1
Dimitrakopoulos, A; Kalofonos, HP; Karabelis, A; Kosmas, C; Koutras, A; Makatsoris, T; Mylonakis, N; Polyzos, A; Spyropoulos, K; Tsavaris, N; Tzelepis, G	1
Anderson, H; Ashcroft, L; Baka, S; Booton, R; Dark, G; Dunlop, D; Laurence, V; Lorigan, P; Nicolson, M; O'Brien, M; O'Byrne, K; Snee, M; Thatcher, N	1
Aragoncillo, P; Casado Herraez, A; Díaz-Rubio García, E; Gómez Díaz, R; Moreno Antón, F; Puente Vázquez, J	1
Budd, GT; Elson, P; Suppiah, R; Wood, L	1
Admirand, JH; Bueso-Ramos, CE; Ford, RJ; Jiang, L; Moran, C	1
Magee, CC; Mendez, GP; Rennke, HG; Schlondorff, JS	1
Gassiamis, A; Karabelis, A; Kosmas, C; Malamos, N; Mylonakis, N; Polyzos, A; Tsakonas, G; Tsavaris, N	1
Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J	1
Gassiamis, A; Karabelis, A; Kosmas, C; Malamos, N; Mylonakis, N; Polyzos, A; Skopelitis, H; Tsakonas, G; Tsavaris, N	1
Ashcroft, L; Booton, R; Heighway, J; Morris, J; Thatcher, N; Ward, T	1
Kakutani, S; Kitamura, T; Kume, H; Tomita, K	1
Bisegna, R; Bratta, M; Candeloro, G; Di Staso, M; Necozione, S; Rea, S; Recchia, F; Tombolini, V	1
Alexandrova, EN; Istomin, YP; Petrovich, SV; Sergeyeva, OP; Zhavrid, EA	1
Chang, H; Choi, HJ; Chung, HC; Kim, JH; Kim, SI; Kim, YT; Koo, JS; Moon, YW; Park, BW; Park, S; Roh, JK; Sohn, JH	1
Altintas, S; Dyck, J; Huizing, MT; Schrijvers, D; Specenier, PM; Van Den Brande, J; Van Den Weyngaert, D; Van Laer, C; Vermorken, JB	1
Dyck, J; Huizing, MT; Rasschaert, M; Schrijvers, D; Specenier, P; Van den Brande, J; Vermorken, JB	1
Birnbaum, A; DiPetrillo, T; Kennedy, T; Rathore, B; Rathore, R; Ready, N	1
Bui-Nguyen, B; Italiano, A; Toulmonde, M	1
Contreras Ibáñez, JA; Díaz Gómez, L; Navas García, N	1
Candeloro, G; Desideri, G; Necozione, S; Piazze, J; Rea, S; Recchia, CO; Recchia, F	1
Pazos Arias, B; Peteiro Cancelo, A; Romero Reinoso, C; Samprón Rodríguez, M; Vello Román, A	1
Collins, IM; Thomas, DM	1
Amedio, J; Jones, B; Komarnitsky, P; Miller, GT; Wallner, BP	1
Chen, Y; Shi, Y; Wang, C; Yang, Y	1
He, A; Huang, Y; Qi, W; Shen, Z; Sun, Y; Yang, Y; Yao, Y; Zhao, H	1
Hervonen, P; Kellokumpu-Lehtinen, P; Tulijoki, T	1
Burnside, N; MacGowan, SW	1
Arai, Y; Ishidoya, S; Ito, A; Kaiho, Y; Mitsuzuka, K; Miyazato, M; Nakagawa, H; Namiki, S; Ohara, S; Saito, H; Yamada, S; Yamashita, S	1
Ozdemir, O; Ozdemir, P; Ozhan, MH; Uluer, H; Veral, A	1
Araki, N; Fukuda, H; Hiraga, H; Iwamoto, Y; Kataoka, K; Kawai, A; Kimura, A; Matsumine, A; Matsunobu, T; Mizusawa, J; Oda, Y; Tanaka, K	1
Cho, H; Kim, JH; Kim, S; Kim, SW; Kim, YT; Lee, M; Nam, EJ	1
Wang, W; Wang, Z; Xiao, X	1
Fujimura, T; Fukuhara, H; Hattori, M; Homma, Y; Igawa, Y; Kakutani, S; Kume, H; Miyazaki, H; Nagata, M; Nakagawa, T; Niimi, A; Taguchi, S	1
Baker, LH; Biermann, JS; Chugh, R; Davis, EJ; Feng, M; Jacobson, J; Lucas, DR; Metko, G; Reinke, D; Schuetze, SM; Wong, SL; Zalupski, MM; Zhao, L; Zyczynski, L	1
Fujisawa, Y; Nakamura, Y; Sato, S; Teramoto, Y; Yamada, K; Yamamoto, A	1
Don, LF; Long, JP; Wan, F; Zhang, F; Zhou, J	1
Fujita, H; Kadono, T; Kimura, T; Masui, Y; Miyagaki, T; Miyagawa, T; Saigusa, R; Sato, S; Yamada, D; Yoshizaki, A	1
Inatsu, H; Kitamura, K; Nakashima, K	1
Chinnakotla, S; Eidenschink, B; Luquette, M; Neglia, J; Pilbeam, K; Sulciner, M	1
Cai, QL; Li, G; Niu, YJ; Wang, Z; Xu, J; Yang, X; Zhang, HT; Zhu, SM	1
Ebata, T; Fujiwara, K; Fujiwara, Y; Hasegawa, K; Kato, T; Nishikawa, T; Noguchi, E; Shimomura, A; Sudo, K; Tamura, K; Yonemori, K	1
Abe, S; Akisue, T; Asanuma, K; Emori, M; Fukuda, H; Furuta, T; Hatano, H; Hiraga, H; Hiraoka, K; Hiruma, T; Iwamoto, Y; Katagiri, H; Kataoka, T; Kawai, A; Kawano, M; Kawashima, H; Machida, R; Matsumoto, Y; Morii, T; Nagano, A; Nakayama, R; Nishida, Y; Okuma, T; Outani, H; Ozaki, T; Suehara, Y; Takenaka, S; Takeyama, M; Tanaka, K; Toguchida, J; Tsukushi, S; Watanuki, M; Yamamoto, T; Yonemoto, T	1
Bonnabry, P; Fleury-Souverain, S; Guillarme, D; Maurin, J; Rudaz, S	1

Reviews

18 review(s) available for ifosfamide and docetaxel anhydrous

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
New cytostatic agents for the treatment of head and neck cancer. Acta oto-rhino-laryngologica Belgica, 1997, Volume: 51, Issue:2 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials, Phase III as Topic; Deoxycytidine; Docetaxel; Fluorouracil; Gemcitabine; Head and Neck Neoplasms; Humans; Ifosfamide; Paclitaxel; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Taxoids	1997
Ifosfamide and docetaxel in non-small cell lung cancer. Seminars in oncology, 1998, Volume: 25, Issue:1 Suppl 2 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Docetaxel; Humans; Ifosfamide; Lung Neoplasms; Paclitaxel; Taxoids	1998
In-vitro metabolism of anti-cancer drugs, methods and applications: paclitaxel, docetaxel, tamoxifen and ifosfamide. Cancer treatment reviews, 1998, Volume: 24, Issue:5 Topics: Animals; Antineoplastic Agents; Cytochrome P-450 Enzyme System; Docetaxel; Drug Interactions; Humans; Ifosfamide; Models, Chemical; Paclitaxel; Species Specificity; Tamoxifen; Taxoids; Tumor Cells, Cultured	1998
Docetaxel (Taxotere) in non-small cell lung cancer: ongoing studies in Heidelberg and future plans. Seminars in oncology, 1999, Volume: 26, Issue:3 Suppl 11 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Paclitaxel; Palliative Care; Radiotherapy, Adjuvant; Taxoids	1999
New options in the treatment of non-small cell lung cancer. Anti-cancer drugs, 1999, Volume: 10 Suppl 1 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Docetaxel; Humans; Ifosfamide; Lung Neoplasms; Multicenter Studies as Topic; Paclitaxel; Randomized Controlled Trials as Topic; Taxoids; Vinblastine; Vinorelbine	1999
Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions. Seminars in oncology, 2000, Volume: 27, Issue:4 Suppl 8 Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Deoxycytidine; Docetaxel; Gemcitabine; Head and Neck Neoplasms; Humans; Ifosfamide; Neoplasm Recurrence, Local; Paclitaxel; Taxoids; Vinblastine; Vinorelbine	2000
Chemotherapy in metastatic non-small-cell lung cancer. Oncology (Williston Park, N.Y.), 2000, Volume: 14, Issue:7 Suppl 5 Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Ifosfamide; Irinotecan; Lung Neoplasms; Mitomycin; Paclitaxel; Taxoids; Tirapazamine; Triazines; Vinblastine; Vinorelbine	2000
Second-line chemotherapy for non-small-cell lung cancer. Current oncology reports, 2000, Volume: 2, Issue:1 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Docetaxel; Drug Resistance, Neoplasm; Health Status; Humans; Ifosfamide; Lung Neoplasms; Paclitaxel; Randomized Controlled Trials as Topic; Survival Analysis; Taxoids; Vinblastine; Vinorelbine	2000
Review of two phase III randomized trials of single-agent docetaxel in previously treated advanced non--small cell lung cancer. Seminars in oncology, 2001, Volume: 28, Issue:3 Suppl 9 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase III as Topic; Docetaxel; Humans; Ifosfamide; Lung Neoplasms; Paclitaxel; Quality of Life; Radiation-Sensitizing Agents; Randomized Controlled Trials as Topic; Survival Rate; Taxoids; Vinblastine; Vinorelbine	2001
Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 2001, Volume: 34 Suppl 4 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Deoxycytidine; Docetaxel; Doxorubicin; Enzyme Inhibitors; Etoposide; Gemcitabine; Humans; Ifosfamide; Irinotecan; Lung Neoplasms; Paclitaxel; Taxoids; Topoisomerase I Inhibitors; Topotecan; Vinblastine; Vinorelbine	2001
Epithelial ovarian cancer. Current treatment options in oncology, 2002, Volume: 3, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bridged-Ring Compounds; Combined Modality Therapy; Deoxycytidine; Docetaxel; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Neoplasm Recurrence, Local; Ovarian Neoplasms; Paclitaxel; Platinum Compounds; Practice Guidelines as Topic; Tamoxifen; Taxoids; Topotecan; Vinblastine; Vinorelbine	2002
Antiblastic drug combinations with ifosfamide: an update. Oncology, 2003, Volume: 65 Suppl 2 Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Deoxycytidine; Docetaxel; Drug Administration Schedule; Gemcitabine; Humans; Ifosfamide; Paclitaxel; Taxoids; Vinblastine; Vinorelbine	2003
[Current strategy of chemotherapy for reflactory bone and soft tissue sarcomas]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bone Neoplasms; Carboplatin; Cisplatin; Clinical Trials, Phase II as Topic; Docetaxel; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Imatinib Mesylate; Lung Neoplasms; Piperazines; Prognosis; Pyrimidines; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Taxoids	2004
Docetaxel in the treatment of esophageal cancer. Seminars in oncology, 2005, Volume: 32, Issue:2 Suppl 4 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Esophageal Neoplasms; Fluorouracil; Gemcitabine; Humans; Ifosfamide; Irinotecan; Neoadjuvant Therapy; Taxoids	2005
[Chemotherapy options for patients with advanced soft-tissue sarcoma beyond anthracyclines]. Bulletin du cancer, 2010, Volume: 97, Issue:6 Topics: Antineoplastic Agents; Dacarbazine; Deoxycytidine; Dioxoles; Docetaxel; Doxorubicin; Gemcitabine; Humans; Ifosfamide; Leiomyosarcoma; Liposarcoma; Sarcoma; Soft Tissue Neoplasms; Taxoids; Tetrahydroisoquinolines; Trabectedin	2010
Malignant primary cardiac tumours. Interactive cardiovascular and thoracic surgery, 2012, Volume: 15, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cardiac Surgical Procedures; Chemotherapy, Adjuvant; Deoxycytidine; Docetaxel; Doxorubicin; Fatal Outcome; Female; Gemcitabine; Heart Neoplasms; Humans; Ifosfamide; Male; Middle Aged; Myxoma; Neoplasm Recurrence, Local; Reoperation; Sarcoma; Taxoids; Time Factors; Treatment Outcome	2012
The role of chemotherapy for metastatic, relapsed and refractory osteosarcoma. Paediatric drugs, 2014, Volume: 16, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyclophosphamide; Deoxycytidine; Docetaxel; Etoposide; Gemcitabine; Humans; Ifosfamide; Methotrexate; Neoplasm Recurrence, Local; Osteosarcoma; Taxoids	2014

Trials

29 trial(s) available for ifosfamide and docetaxel anhydrous

Article	Year
Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours. British journal of cancer, 1998, Volume: 77, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Nausea; Neoplasms; Neutropenia; Paclitaxel; Taxoids; Vomiting	1998
Docetaxel and ifosfamide in patients with advanced solid tumors: results of a phase I study. Seminars in oncology, 1998, Volume: 25, Issue:1 Suppl 2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Feasibility Studies; Female; Humans; Ifosfamide; Male; Middle Aged; Neoplasms; Paclitaxel; Taxoids	1998
New chemotherapy combinations with docetaxel in the treatment of patients with non-small cell lung cancer. Seminars in oncology, 1998, Volume: 25, Issue:3 Suppl 8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lenograstim; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Recombinant Proteins; Taxoids	1998
The use of docetaxel (Taxotere) in patients with advanced non-small cell lung cancer previously treated with platinum-containing chemotherapy regimens. Seminars in oncology, 1999, Volume: 26, Issue:3 Suppl 11 Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Docetaxel; Humans; Ifosfamide; Lung Neoplasms; Paclitaxel; Platinum Compounds; Quality of Life; Sickness Impact Profile; Survival Analysis; Taxoids; Vinblastine; Vinorelbine	1999
Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:12 Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Survival Analysis; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine	2000
Pharmacokinetics of ifosfamide are changed by combination with docetaxel: results of a phase I pharmacologic study. American journal of clinical oncology, 2000, Volume: 23, Issue:4 Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Chromatography, High Pressure Liquid; Confidence Intervals; Dexamethasone; Docetaxel; Drug Administration Schedule; Drug Interactions; Female; Gas Chromatography-Mass Spectrometry; Glucocorticoids; Half-Life; Humans; Ifosfamide; Infusions, Intravenous; Male; Metabolic Clearance Rate; Methylprednisolone; Middle Aged; Paclitaxel; Taxoids	2000
Docetaxel and ifosfamide as second line treatment for patients with advanced or metastatic urothelial cancer after failure of platinum chemotherapy: a phase 2 study. The Journal of urology, 2001, Volume: 165, Issue:1 Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Disease-Free Survival; Docetaxel; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Middle Aged; Paclitaxel; Prospective Studies; Taxoids; Treatment Failure; Urologic Neoplasms	2001
Docetaxel as rescue medication in anthracycline- and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: results of a phase II trial. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:9 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Disease Progression; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Ifosfamide; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Sarcoma; Soft Tissue Neoplasms; Taxoids; Treatment Outcome	2001
A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer. International journal of cancer, 2002, Mar-01, Volume: 98, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Patient Compliance; Taxoids	2002
Phase I study of docetaxel plus ifosfamide in patients with advanced cancer. British journal of cancer, 2002, Oct-07, Volume: 87, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Female; Gastrointestinal Diseases; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Paclitaxel; Taxoids	2002
[Comparison of effects of three chemotherapy regimens for advanced non-small cell lung cancer]. Ai zheng = Aizheng = Chinese journal of cancer, 2002, Volume: 21, Issue:12 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Paclitaxel; Taxoids; Treatment Outcome	2002
Phase II study of docetaxel and ifosfamide combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy with or without paclitaxel. Lung cancer (Amsterdam, Netherlands), 2003, Volume: 39, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Docetaxel; Female; Humans; Ifosfamide; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Salvage Therapy; Survival Rate; Taxoids; Treatment Failure	2003
Phase I-II study of docetaxel and ifosfamide combination in patients with anthracycline pretreated advanced breast cancer. British journal of cancer, 2003, Apr-22, Volume: 88, Issue:8 Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Ifosfamide; Infusions, Intravenous; Middle Aged; Survival Analysis; Taxoids; Treatment Failure	2003
Docetaxel-ifosfamide combination chemotherapy in patients with metastatic hormone-refractory prostate cancer: a phase I pharmacokinetic study. International journal of clinical pharmacology research, 2003, Volume: 23, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Docetaxel; Humans; Ifosfamide; Male; Metabolic Clearance Rate; Prostatic Neoplasms; Taxoids	2003
Combination chemotherapy of docetaxel, ifosfamide and cisplatin (DIP) in patients with metastatic urothelial cancer: a preliminary report. Japanese journal of clinical oncology, 2005, Volume: 35, Issue:2 Topics: Aged; Aged, 80 and over; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Soft Tissue Neoplasms; Taxoids; Thrombocytopenia; Urologic Neoplasms	2005
A phase II study of the docetaxel-ifosfamide-carboplatin combination in advanced non-small-cell lung cancer. Oncology, 2005, Volume: 69, Issue:4 Topics: Actuarial Analysis; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Docetaxel; Drug Administration Schedule; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Quality of Life; Survival Analysis; Taxoids; Treatment Outcome	2005
A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: a randomised multicentre trial of the British Thoracic Oncology Group Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Staging; Quality of Life; Survival Analysis; Taxoids; Vinblastine	2006
Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS). Investigational new drugs, 2006, Volume: 24, Issue:6 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Doxorubicin; Female; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Middle Aged; Sarcoma; Survival Analysis; Taxoids	2006
Docetaxel-ifosfamide combination in patients with HER2-non-overexpressing advanced breast cancer failing prior anthracyclines. Investigational new drugs, 2007, Volume: 25, Issue:5 Topics: Adult; Aged; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Female; Humans; Ifosfamide; Middle Aged; Receptor, ErbB-2; Taxoids	2007
Docetaxel-ifosfamide combination in patients with advanced breast cancer failing prior anthracycline-based regimens: results of a phase I-II study. Journal of chemotherapy (Florence, Italy), 2007, Volume: 19, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Dose-Response Relationship, Drug; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Maximum Tolerated Dose; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; Taxoids	2007
ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2007, Volume: 2, Issue:10 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; DNA Repair; DNA-Binding Proteins; Docetaxel; Endonucleases; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mitomycin; Neoplasm Staging; Neoplasms, Squamous Cell; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Taxoids; Treatment Outcome	2007
Maintenance immunotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck. Journal of immunotherapy (Hagerstown, Md. : 1997), 2008, Volume: 31, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; CD4-CD8 Ratio; Cisplatin; Disease-Free Survival; Docetaxel; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Immunotherapy; Killer Cells, Natural; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; T-Lymphocytes; Taxoids	2008
Docetaxel, ifosfamide and cisplatin (DIP) in squamous cell carcinoma of the head and neck. Anticancer research, 2009, Volume: 29, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Case-Control Studies; Cisplatin; Disease Progression; Docetaxel; Female; Head and Neck Neoplasms; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Prognosis; Survival Rate; Taxoids	2009
Docetaxel, ifosfamide and cisplatin in solid tumour treatment: a phase I study. Anti-cancer drugs, 2010, Volume: 21, Issue:3 Topics: Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Brain Injuries; Canada; Cerebral Infarction; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Mesna; Middle Aged; Neoplasms; Neutropenia; Taxoids; Thrombocytopenia	2010
Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: a phase I Brown University Oncology Group dose escalation study (HN-93). Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Feasibility Studies; Female; Head and Neck Neoplasms; Hospitals, University; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Taxoids; Treatment Outcome	2010
No additional benefit of adding ifosfamide to docetaxel in castration-resistant metastatic prostate cancer. Anticancer research, 2012, Volume: 32, Issue:8 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Metastasis; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids	2012
A randomized phase II/III trial of perioperative chemotherapy with adriamycin plus ifosfamide versus gemcitabine plus docetaxel for high-grade soft tissue sarcoma: Japan Clinical Oncology Group Study JCOG1306. Japanese journal of clinical oncology, 2014, Volume: 44, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Docetaxel; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Japan; Male; Middle Aged; Neoplasm Staging; Postoperative Period; Sarcoma; Soft Tissue Neoplasms; Taxoids; Tomography, X-Ray Computed; Treatment Outcome	2014
A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma. European journal of cancer (Oxford, England : 1990), 2015, Volume: 51, Issue:13 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Deoxycytidine; Disease Progression; Disease-Free Survival; Docetaxel; Doxorubicin; Female; Gemcitabine; Hospitalization; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Michigan; Middle Aged; Neoadjuvant Therapy; Proportional Hazards Models; Radiotherapy, Adjuvant; Sarcoma; Soft Tissue Neoplasms; Taxoids; Time Factors; Treatment Outcome; Young Adult	2015
Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306. British journal of cancer, 2022, Volume: 127, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Doxorubicin; Febrile Neutropenia; Gemcitabine; Humans; Ifosfamide; Sarcoma; Soft Tissue Neoplasms	2022

Other Studies

36 other study(ies) available for ifosfamide and docetaxel anhydrous

Article	Year
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Some Anticancer Agents Act on Human Serum Paraoxonase-1 to Reduce Its Activity. Chemical biology & drug design, 2016, Volume: 88, Issue:2 Topics: Antineoplastic Agents; Aryldialkylphosphatase; Electrophoresis, Polyacrylamide Gel; Humans	2016
Efficacy of docetaxel in the second-line treatment of locally advanced or metastatic soft tissue sarcoma after failure of chemotherapy with anthracycline or ifosfamide. American journal of clinical oncology, 1999, Volume: 22, Issue:5 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Ifosfamide; Male; Paclitaxel; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Taxoids	1999
Possible metabolic interaction between docetaxel and ifosfamide. British journal of cancer, 2000, Volume: 82, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Humans; Ifosfamide; Liver; Microsomes; Neoplasms; Paclitaxel; Taxoids	2000
A preclinical model for experimental chemotherapy of human head and neck cancer. International journal of oncology, 2001, Volume: 18, Issue:6 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Body Weight; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Disease Models, Animal; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Ifosfamide; Methotrexate; Mice; Mice, Nude; Paclitaxel; Survival Rate; Taxoids	2001
[An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2002, Volume: 40, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Carboplatin; Cisplatin; Dacarbazine; Deoxycytidine; Docetaxel; Drug Administration Schedule; Etoposide; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Osteosarcoma; Paclitaxel; Spinal Cord Neoplasms; Survivors; Taxoids; Vincristine; Vindesine	2002
A mouse model for the study of factors affecting angiogenesis. Pharmacology & toxicology, 2002, Volume: 90, Issue:3 Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Docetaxel; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Humans; Ifosfamide; Injections, Subcutaneous; Mice; Neovascularization, Pathologic; Paclitaxel; Prostheses and Implants; Surgical Sponges; Taxoids	2002
Vinorelbine, ifosfamide, and cisplatin combination as salvage chemotherapy in advanced non-small cell lung cancer. Japanese journal of clinical oncology, 2003, Volume: 33, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Ifosfamide; Leukopenia; Lung Neoplasms; Male; Middle Aged; Prognosis; Quality of Life; Salvage Therapy; Survival Rate; Taxoids; Vinblastine; Vinorelbine	2003
[A case of oropharyngeal cancer with multiple bone metastases from prostate cancer that responded to docetaxel, ifosfamide and cisplatin combination therapy]. Gan to kagaku ryoho. Cancer & chemotherapy, 2005, Volume: 32, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Drug Administration Schedule; Humans; Ifosfamide; Infusions, Intravenous; Male; Oropharyngeal Neoplasms; Prostatic Neoplasms; Quality of Life; Taxoids	2005
Pre-chemotherapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who received a first-line taxane/platinum-based regimen: results of a multicenter retrospective Italian study. Gynecologic oncology, 2005, Volume: 98, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Docetaxel; Epithelial Cells; Female; Hemoglobins; Humans; Ifosfamide; Middle Aged; Ovarian Neoplasms; Paclitaxel; Prognosis; Retrospective Studies; Taxoids	2005
Cardiac metastasis from uterine leiomyosarcoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Deoxycytidine; Diagnostic Errors; Docetaxel; Doxorubicin; Fatal Outcome; Female; Gemcitabine; Heart Neoplasms; Humans; Hysterectomy; Ifosfamide; Kidney Neoplasms; Leiomyoma; Leiomyosarcoma; Lung Neoplasms; Middle Aged; Ovariectomy; Taxoids; Temozolomide; Thoracic Surgery, Video-Assisted; Uterine Neoplasms	2006
Mediastinal follicular dendritic cell sarcoma involving bone marrow: a case report and review of the literature. Annals of diagnostic pathology, 2006, Volume: 10, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Dendritic Cells, Follicular; Deoxycytidine; Docetaxel; Etoposide; Female; Gemcitabine; Humans; Ifosfamide; Immunoenzyme Techniques; Mediastinal Neoplasms; Methotrexate; Middle Aged; Sarcoma; Taxoids; Treatment Outcome	2006
Electrolyte abnormalities and progressive renal failure in a cancer patient. Kidney international, 2007, Volume: 71, Issue:11 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Biopsy; Creatinine; Deoxycytidine; Diagnosis, Differential; Disease Progression; Docetaxel; Drug Administration Schedule; Fibrosarcoma; Follow-Up Studies; Gastrointestinal Stromal Tumors; Gemcitabine; Humans; Ifosfamide; Inflammation; Kidney; Kidney Glomerulus; Kidney Tubules; Male; Middle Aged; Renal Insufficiency; Taxoids; Treatment Outcome; Water-Electrolyte Imbalance	2007
Salvage therapy for Chinese non-small cell lung cancer patients who failed previous chemotherapy. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2006, Volume: 1, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gefitinib; Gemcitabine; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Probability; Prognosis; Quinazolines; Retrospective Studies; Risk Factors; Salvage Therapy; Statistics, Nonparametric; Survival Analysis; Taiwan; Taxoids; Treatment Outcome	2006
Salvage combination chemotherapy with docetaxel, ifosfamide and cisplatin (DIP): successful treatment of a case with metastatic testicular immature teratoma. Japanese journal of clinical oncology, 2008, Volume: 38, Issue:2 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Humans; Ifosfamide; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Mediastinum; Salvage Therapy; Taxoids; Teratoma; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome	2008
Dose enhancement effect of anticaner drugs associated with increased temperature in vitro. Experimental oncology, 2008, Volume: 30, Issue:1 Topics: Antineoplastic Agents; Carboplatin; Cell Proliferation; Cell Survival; Combined Modality Therapy; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Gemcitabine; HeLa Cells; Humans; Hyperthermia, Induced; Ifosfamide; Organoplatinum Compounds; Oxaliplatin; Taxoids; Temperature; Vinblastine; Vinorelbine	2008
Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance. Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:3 Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Docetaxel; Drug Resistance, Neoplasm; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel; Retrospective Studies; Survival Rate; Taxoids; Treatment Outcome	2010
Mestastatic gastric cancer from malignant fibrous histiocytoma. Revista espanola de enfermedades digestivas, 2011, Volume: 103, Issue:1 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Dioxoles; Docetaxel; Epirubicin; Fatal Outcome; Gemcitabine; Histiocytoma, Malignant Fibrous; Humans; Ifosfamide; Lung Neoplasms; Male; Soft Tissue Neoplasms; Spinal Neoplasms; Stomach Neoplasms; Taxoids; Tetrahydroisoquinolines; Thigh; Thoracic Vertebrae; Trabectedin	2011
Premenopausal hormone-responsive breast cancer with extensive axillary nodes involvement: total estrogen blockade and chemotherapy. Anticancer research, 2011, Volume: 31, Issue:2 Topics: Adult; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Docetaxel; Epirubicin; Estriol; Estrogen Antagonists; Female; Humans; Ifosfamide; Leuprolide; Lymphatic Metastasis; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Premenopause; Receptors, Estrogen; Receptors, Progesterone; Taxoids; Triazoles; Tumor Necrosis Factor Ligand Superfamily Member 15	2011
[Nephropathy following administration of angiogenesis inhibitors]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2011, Volume: 31, Issue:2 Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bowman Capsule; Dacarbazine; Deoxycytidine; Disease Progression; Docetaxel; Doxorubicin; Endothelium, Vascular; Fibrosarcoma; Gemcitabine; Glomerulonephritis, Membranoproliferative; Humans; Ifosfamide; Lung Neoplasms; Male; Mesna; Muscle Neoplasms; Podocytes; Proteinuria; Taxoids; Vascular Endothelial Growth Factor A	2011
Novel approaches to treatment of leiomyosarcomas. Current oncology reports, 2011, Volume: 13, Issue:4 Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Doxorubicin; Enzyme Inhibitors; Gemcitabine; Humans; Ifosfamide; Leiomyosarcoma; Molecular Targeted Therapy; Neoplasm Metastasis; Poly(ADP-ribose) Polymerase Inhibitors; Taxoids	2011
Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin. Anti-cancer drugs, 2012, Volume: 23, Issue:2 Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Ifosfamide; Injections, Intravenous; Leukemia, Experimental; Lysine; Male; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Phosphoramide Mustards; Rats; Rats, Sprague-Dawley; Taxoids; Xenograft Model Antitumor Assays	2012
Adjuvant chemotherapy decreases and postpones distant metastasis in extremity stage IIB/III synovial sarcoma patients. Journal of surgical oncology, 2012, Aug-01, Volume: 106, Issue:2 Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Dacarbazine; Deoxycytidine; Disease-Free Survival; Docetaxel; Doxorubicin; Drug Administration Schedule; Extremities; Female; Gemcitabine; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Mesna; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy, Adjuvant; Remission Induction; Sarcoma, Synovial; Soft Tissue Neoplasms; Taxoids	2012
Comparison of pirarubicin-based versus gemcitabine-docetaxel chemotherapy for relapsed and refractory osteosarcoma: a single institution experience. International journal of clinical oncology, 2013, Volume: 18, Issue:3 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Deoxycytidine; Disease-Free Survival; Docetaxel; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Female; Gemcitabine; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Middle Aged; Osteosarcoma; Prospective Studies; Taxoids	2013
Salvage chemotherapy with docetaxel, ifosfamide and nedaplatin (DIN) for patients with advanced germ cell tumors: a preliminary report. Japanese journal of clinical oncology, 2013, Volume: 43, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Ifosfamide; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Recurrence; Salvage Therapy; Taxoids; Testicular Neoplasms; Treatment Outcome	2013
ERCC1 expression does not predict survival and treatment response in advanced stage non-small cell lung cancer cases treated with platinum based chemotherapy. Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; DNA-Binding Proteins; Docetaxel; Endonucleases; Female; Follow-Up Studies; Glutamates; Guanine; Humans; Ifosfamide; Immunoenzyme Techniques; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Pemetrexed; Prognosis; Retrospective Studies; Survival Rate; Taxoids	2013
ATP-based chemotherapy response assay in primary or recurrent ovarian and peritoneal cancer. Yonsei medical journal, 2014, Volume: 55, Issue:6 Topics: Adenocarcinoma, Clear Cell; Adenosine Triphosphate; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Ovarian Epithelial; Cisplatin; Docetaxel; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Ifosfamide; Irinotecan; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Predictive Value of Tests; Sensitivity and Specificity; Taxoids	2014
Combination of docetaxel, ifosfamide and cisplatin (DIP) as a potential salvage chemotherapy for metastatic urothelial carcinoma. Japanese journal of clinical oncology, 2015, Volume: 45, Issue:3 Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Female; Humans; Ifosfamide; Karnofsky Performance Status; Leukopenia; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies; Salvage Therapy; Taxoids; Thrombocytopenia; Treatment Outcome; Urologic Neoplasms	2015
Long-term control of pleural metastasis in Stewart-Treves syndrome with single-agent chemotherapies followed by maintenance chemotherapy. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2015, Volume: 13, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Doxorubicin; Drug Administration Schedule; Female; Hemangiosarcoma; Humans; Ifosfamide; Induction Chemotherapy; Longitudinal Studies; Lymphangiosarcoma; Maintenance Chemotherapy; Middle Aged; Pleural Neoplasms; Skin Neoplasms; Taxoids; Treatment Outcome	2015
DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer. European review for medical and pharmacological sciences, 2016, Volume: 20, Issue:6 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Estradiol; Female; Fluorouracil; Follicle Stimulating Hormone; Humans; Ifosfamide; Incidence; Luteinizing Hormone; Middle Aged; Primary Ovarian Insufficiency; Reproduction; Taxoids	2016
Pazopanib induced a partial response in a patient with metastatic fibrosarcomatous dermatofibrosarcoma protuberans without genetic translocations resistant to mesna, doxorubicin, ifosfamide and dacarbazine chemotherapy and gemcitabine-docetaxel chemothera The Journal of dermatology, 2017, Volume: 44, Issue:3 Topics: Abdomen; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Deoxycytidine; Dermatofibrosarcoma; Docetaxel; Doxorubicin; Drug Resistance, Neoplasm; Fatal Outcome; Gemcitabine; Humans; Ifosfamide; Indazoles; Male; Mesna; Middle Aged; Pyrimidines; Skin Neoplasms; Sulfonamides	2017
Primary Cardiac Leiomyosarcoma: A 27-Month Survival with Surgery and Chemotherapy. Internal medicine (Tokyo, Japan), 2017, Aug-15, Volume: 56, Issue:16 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Deoxycytidine; Docetaxel; Doxorubicin; Fatal Outcome; Gemcitabine; Heart Neoplasms; Humans; Ifosfamide; Indoles; Leiomyosarcoma; Life Support Care; Male; Mesna; Pyrroles; Sunitinib; Taxoids	2017
Success of chemotherapy and a liver transplant in a pediatric patient with hepatic angiosarcoma: A case report. Pediatric transplantation, 2019, Volume: 23, Issue:4 Topics: Antineoplastic Agents; Biopsy; Child, Preschool; Docetaxel; Doxorubicin; Female; Hemangiosarcoma; Humans; Ifosfamide; Liver; Liver Neoplasms; Liver Transplantation; Neoplasm Recurrence, Local; Treatment Outcome	2019
Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis. BMC cancer, 2019, Jun-25, Volume: 19, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Disease Progression; Docetaxel; Humans; Ifosfamide; Inguinal Canal; Kaplan-Meier Estimate; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Penile Neoplasms; Penis; Taxoids	2019
Treatment Outcome of Second-Line Chemotherapy for Gynecologic Carcinosarcoma. Oncology, 2020, Volume: 98, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinosarcoma; Docetaxel; Doxorubicin; Female; Humans; Ifosfamide; Indazoles; Middle Aged; Ovarian Neoplasms; Paclitaxel; Prognosis; Progression-Free Survival; Pyrimidines; Retrospective Studies; Sulfonamides; Treatment Outcome; Uterine Neoplasms	2020
Development and application of a liquid chromatography coupled to mass spectrometry method for the simultaneous determination of 23 antineoplastic drugs at trace levels. Journal of pharmaceutical and biomedical analysis, 2022, Nov-30, Volume: 221 Topics: Antineoplastic Agents; Busulfan; Carboplatin; Chromatography, Liquid; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Docetaxel; Doxorubicin; Epirubicin; Etoposide; Fluorouracil; Ganciclovir; Humans; Idarubicin; Ifosfamide; Irinotecan; Methanol; Methotrexate; Oxaliplatin; Paclitaxel; Pemetrexed; Tandem Mass Spectrometry; Topotecan; Vinblastine; Vincristine; Water	2022